Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0340 per EA under NDC 70010010910. Its NADAC has been published 262 times since Jan 6, 2021.
Strength
300 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010010910
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
12/17/2025
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA075360On Market Since
9/7/2020
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 262 times since Jan 6, 2021, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0340 per EA |
|---|---|
| All-time high | $0.0537 (Nov 10, 2021) |
| All-time low | $0.0313 (Nov 20, 2024) |
| 52-week high | $0.0361 |
| 52-week low | $0.0337 |
| Median price | $0.0427 |
| Average price | $0.0425 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 262 |
| Tracking since | Jan 6, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.0340 per EA (NDC 70010010910), effective Jan 7, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 32.4%. It has been tracked across 262 weekly CMS publications since Jan 6, 2021.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Jan 6, 2021, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0313 (Nov 20, 2024) to a high of $0.0537 (Nov 10, 2021), with a median of $0.0427 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0324 per EA — about 5% below GABAPENTIN 300 MG CAPSULE.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 70010010910) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification